Heidi Petersen, MPH
Heidi Petersen has been working in the Biotech Industry for more than 30 years. She led Regulatory Affairs and Quality at multiple companies and managed global programs at all stages of drug development. Heidi has deep experience with guiding global development of biologic and small molecule products across immuno-oncology, pediatric rare disease, and infectious disease indications, among others. She is highly effective in regulatory agency interactions and cross-functional team leadership, delivering successful outcomes under tight timelines. A trusted thought partner to senior leadership and boards, Heidi is known for clarity of communication, strong judgment, and hands-on problem-solving. Heidi thrives in collaborative, mission-driven environments. Heidi has a BS in Biology from Tulane University and an MPH from Columbia University.
Jessica Bockhorn, PhD
Jessica Bockhorn’s strong science background in chemistry and molecular biology has been instrumental in her ability to navigate the regulatory approach to, and challenges associated with, the development of complex drug technologies. She has broad experience with US and ex-US health authority submissions and interactions on small molecules, vaccines and other biologic products in oncology, HIV and Hepatitis indications, among others. She has excellent communication and presentation skills and thrives when working with cross-functional, global teams in fast-paced environments. Jessica has more than nine years of cancer biology research experience where she focused on the evaluation and characterization of prognostic and therapeutic targets in various model systems. Jessica has a BS in Chemistry and Genetics from Rutgers University and a PhD in Biochemistry and Molecular Biology from The University of Chicago. She was a postdoctoral fellow at Stanford University.